natgillin/translations-raw huggingface dataset:
The collection holder and its staff shall provide all assistance necessary to facilitate the verification referred to in paragraphs 1, 2 and 3.
Imetnik zbirke in njegovo osebje zagotovijo vso potrebno pomoč za lažje preverjanje iz odstavkov 1, 2 in 3.
Remedial actions or measures referred to in Article 5(4) of Regulation (EU) No 511/2014 shall be effective and proportionate and address shortcomings which, if left unaddressed, would permanently compromise the capacity of a registered collection to comply with Article 5(3) of that Regulation.
Popravne dejavnosti ali ukrepi iz člena 5(4) Uredbe (EU) št. 511/2014 so učinkoviti in sorazmerni ter odpravljajo pomanjkljivosti, ki bi, če se ne bi ukrepalo, trajno ogrozile zmožnost registrirane zbirke, da izpolnjuje določbe člena 5(3) navedene uredbe.
They may require the collection holder concerned to put in place additional tools or to improve its capacity to apply existing tools.
Zadevni imetnik zbirke bo morda moral zagotoviti dodatna orodja ali izboljšati svojo zmožnost uporabe že obstoječih orodij.
The collection holder shall report to the competent authority on the implementation of the identified remedial actions or measures.
Imetnik zbirke pristojnemu organu poroča o izvajanju opredeljenih popravnih dejavnosti ali ukrepov.
Due diligence declaration at the stage of research funding
Izjava o primerni skrbnosti na stopnji financiranja raziskav
A recipient of funding for research involving the utilisation of genetic resources and traditional knowledge associated with genetic resources shall make the due diligence declaration requested pursuant to Article 7(1) of Regulation (EU) No 511/2014 to the competent authority of the Member State in which the recipient is established.
Prejemnik sredstev za raziskave, ki vključujejo uporabo genskih virov in tradicionalnega znanja v zvezi z genskimi viri, pristojnemu organu države članice, v kateri ima sedež, da izjavo o primerni skrbnosti v skladu s členom 7(1) Uredbe (EU) št. 511/2014.
If the recipient is not established in the Union and the research is carried out in the Union, the due diligence declaration shall be made to the competent authority of the Member State in which the research is carried out.
Če prejemnik nima sedeža v Uniji in se raziskave izvajajo v Uniji, se izjava o primerni skrbnosti da pristojnemu organu države članice, v kateri se izvajajo raziskave.
The due diligence declaration shall be made by submitting the completed template set out in Annex II.
Izjava o primerni skrbnosti se predloži kot izpolnjena predloga iz Priloge II.
It shall be made after the first instalment of funding has been received and all the genetic resources and traditional knowledge associated with genetic resources that are utilised in the funded research have been obtained, but no later than at the time of the final report, or in absence of such report, at the project end.
Predloži se po prejemu prvega obroka sredstev ter po pridobitvi vseh genskih virov in tradicionalnega znanja v zvezi z genskimi viri, ki se uporabljajo v financiranih raziskavah, toda ne pozneje kot v času končnega poročila ali, če poročila ni, ob koncu projekta.
The time of submission of such declaration may be further specified by the national authorities.
Čas predložitve take izjave lahko nacionalni organi natančneje opredelijo.
Where the same research project is funded from more than one source or involves more than one recipient, the recipient(s) may decide to make only one declaration.
Kadar se isti raziskovalni projekt financira iz več kot enega vira ali vključuje več kot enega prejemnika, se prejemniki lahko odločijo, da dajo samo eno izjavo.
That declaration shall be submitted by the project co-ordinator to the competent authority of the Member State in which the project co-ordinator is established.
Koordinator projekta navedeno izjavo predloži pristojnemu organu države članice, v kateri ima sedež koordinator projekta.
If the project co-coordinator is not established in the Union and the research is carried out in the Union, the due diligence declaration shall be made to the competent authority of one of the Member States in which the research is carried out.
Če koordinator projekta nima sedeža v Uniji in se raziskave izvajajo v Uniji, se izjava o primerni skrbnosti da pristojnemu organu ene od držav članic, v kateri se izvajajo raziskave.
Where the competent authority that receives the declaration referred to in paragraphs 2 and 3 is not responsible for its transmission pursuant to Article 7(3) of Regulation (EU) No 511/2014, it shall forward that declaration to the competent authority responsible for such transmission without undue delay.
Kadar pristojni organ, ki prejme izjavo iz odstavkov 2 in 3, ni pristojen za njeno pošiljanje v skladu s členom 7(3) Uredbe (EU) št. 511/2014, navedeno izjavo brez nepotrebnega odlašanja pošlje pristojnemu organu, pristojnemu za tako pošiljanje.
For the purposes of this Article and Annex II, ‘funding for research’ means any financial contribution by means of a grant to carry out research, whether from commercial or non-commercial sources.
Za namene tega člena in Priloge II „sredstva za raziskave“ pomenijo vsak finančni prispevek v obliki nepovratnih sredstev za izvajanje raziskav iz komercialnih ali nekomercialnih virov.
It does not cover internal budgetary resources of private or public entities
Ne krijejo notranjih proračunskih sredstev zasebnikov ali javnih subjektov.
Due diligence declaration at the stage of final development of a product
Izjava o primerni skrbnosti na zadnji stopnji razvoja proizvoda
For the utilisation of genetic resources and traditional knowledge associated with genetic resources users shall make the due diligence declaration pursuant to Article 7(2) of Regulation (EU) No 511/2014 to the competent authority of the Member State in which the user is established.
Uporabniki za uporabo genskih virov in tradicionalnega znanja v zvezi z genskimi viri pristojnemu organu države članice, v kateri ima uporabnik sedež, dajo izjavo o primerni skrbnosti v skladu s členom 7(2) Uredbe (EU) št. 511/2014.
That declaration shall be made by submitting the completed template set out in Annex III to this Regulation.
Navedena izjava se predloži kot izpolnjena predloga iz Priloge III k tej uredbi.
The due diligence declaration referred to in paragraph 1 shall only be made once, prior to the first of the following events occurring:
Izjava o primerni skrbnosti iz odstavka 1 se da samo enkrat pred prvim izmed naslednjih primerov:
market approval or authorisation is sought for a product developed via the utilisation of genetic resources and traditional knowledge associated with genetic resources;
zaprosi se za dovoljenje za trženje ali promet za proizvod, razvit prek uporabe genskih virov in tradicionalnega znanja v zvezi z genskimi viri,
a notification required prior to placing for the first time on the Union market is made for a product developed via the utilisation of genetic resources and traditional knowledge associated with genetic resources;
potrebna je priglasitev, preden je proizvod, razvit prek uporabe genskih virov in tradicionalnega znanja v zvezi z genskimi viri, prvič dan na trg Unije,
placing on the Union market for the first time a product developed via the utilisation of genetic resources and traditional knowledge associated with genetic resources for which no market approval, authorisation or notification is required;
na trg Unije se prvič da proizvod, razvit prek uporabe genskih virov in tradicionalnega znanja v zvezi z genskimi viri, za katerega niso potrebni niti dovoljenje za trženje ali promet niti priglasitev,
the result of the utilisation is sold or transferred in any other way to a natural or legal person within the Union in order for that person to carry out one of the activities referred to in points (a), (b) and (c);
rezultat uporabe je prodan ali na kakršen koli drug način posredovan fizični ali pravni osebi v Uniji, da navedena oseba izvede eno od dejavnosti iz točk (a), (b) in (c),
the utilisation in the Union has ended and its outcome is sold or transferred in any other way to a natural or legal person outside the Union.
uporaba v Uniji se je končala in njen izid prodal ali na kakršen koli drug način posredoval fizični ali pravni osebi izven Unije.
For the purposes of this Article and Annex III, ‘result of the utilisation’ means products, precursors or predecessors to a product, as well as parts of products to be incorporated into a final product, blueprints or designs, based on which manufacturing and production could be carried out without further utilisation of the genetic resource and traditional knowledge associated with genetic resources.
Za namene tega člena in Priloge III, „rezultat uporabe“ pomeni proizvode, prekurzorje ali predhodnike proizvoda ter dele proizvodov, ki se vključijo v končni proizvod, odtise ali zasnove, na osnovi katerih bi se lahko izvedli izdelava in proizvodnja brez nadaljnje uporabe genskega vira ali tradicionalnega znanja v zvezi z genskimi viri.
For the purposes of this Article and Annex III, ‘placing on the Union market’ means the first making available of a product developed via utilisation of genetic resources and traditional knowledge associated with genetic resources on the Union market, where making available means the supply by any means, for distribution, consumption or use on the Union market in the course of a commercial activity, whether in return for payment or free of charge.
Za namene tega člena in Priloge III „dajanje na trg Unije“ pomeni prvo dajanje proizvoda, razvitega prek uporabe genskih virov in tradicionalnega znanja v zvezi z genskimi viri, na trg Unije, kadar dajanje na voljo pomeni dobavo na kakršen koli način za razdelitev, potrošnjo ali uporabo na trgu Unije v okviru trgovske dejavnosti bodisi za plačilo bodisi brezplačno.
Placing on the market does not include pre-commercial trials, including clinical, field or pest resistance trials, nor the making available of unauthorised medicinal products in order to provide treatment options for individual patients or groups of patients.
Dajanje na trg ne vključuje predkomercialnega preskušanja, vključno s kliničnim, terenskim preskušanjem ali preskušanjem odpornosti na škodljivce, niti dajanja na voljo nedovoljenih zdravil za zagotavljanje možnosti zdravljenja posameznih bolnikov ali skupin bolnikov.
In accordance with Article 7(3) of Regulation (EU) No 511/2014, and unless the information is confidential within the meaning of Article 7(5) of Regulation (EU) No 511/2014, the competent authorities shall transmit to the ABS Clearing House the information received on the basis of Part A of Annexes II and III to this Regulation without undue delay and at the latest one month after the information has been received.
V skladu s členom 7(3) Uredbe (EU) št. 511/2014 pristojni organi brez nepotrebnega odlašanja in najpozneje en mesec po prejemu informacij posredovalnici informacij o dostopu in delitvi koristi pošljejo informacije, ki so jih prejeli na podlagi dela A Prilog II in III k tej uredbi, razen če so informacije tajne v smislu člena 7(5) Uredbe (EU) št. 511/2014.
Where essential information, such as on the user and utilisation, on the place of access, or on the genetic resource, without which the record could not be published on the ABS Clearing House, is considered confidential, the competent authorities shall consider instead transmitting that essential information directly to the competent national authorities referred to in Article 13(2) of the Nagoya Protocol.
Kadar se bistvene informacije, na primer o uporabniku in uporabi, kraju dostopa ali genskem viru, brez katerih ne bi bilo mogoče objaviti zapisa v posredovalnici informacij o dostopu in delitvi koristi, obravnavajo kot tajne, pristojni organi preučijo možnost posredovanja navedenih bistvenih informacij neposredno pristojnim nacionalnim organom iz člena 13(2) Nagojskega protokola.
In accordance with Article 7(3) of Regulation (EU) No 511/2014, the competent authorities shall transmit to the Commission the information received on the basis of Annexes II and III to this Regulation, unless such information is confidential within the meaning of Article 7(5) of Regulation (EU) No 511/2014.
V skladu s členom 7(3) Uredbe (EU) št. 511/2014 pristojni organi Komisiji pošljejo informacije, ki so jih prejeli na podlagi prilog II in III k tej uredbi, razen če so take informacije tajne v smislu člena 7(5) Uredbe (EU) št. 511/2014.
Where the Commission is not provided access to this information on a permanent basis through electronic means, such transmission shall be made once every six months, starting from 9 November 2016.
Kadar Komisija nima zagotovljenega stalnega elektronskega dostopa do teh informacij, se informacije pošljejo vsakih šest mesecev od 9. novembra 2016.
Application for recognition of a best practice
Zahteva za priznanje najboljše prakse
An application submitted in accordance with Article 8(1) of Regulation (EU) No 511/2014 shall be made to the Commission by providing the information and supporting documentation specified in Annex IV to this Regulation.
Zahtevek se v skladu s členom 8(1) Uredbe (EU) št. 511/2014 Komisiji predloži tako, da se zagotovijo informacije in podporna dokumentacija iz Priloge IV k tej uredbi.
An interested party that does not represent users but is involved in the access, collection, transfer or commercialisation of genetic resources or in developing measures and policy related to genetic resources shall provide with its application information, as specified in Annex IV to this Regulation, on its legitimate interest in developing and overseeing a combination of procedures, tools or mechanisms, which, when effectively implemented by a user, enables that user to comply with the obligations provided for in Articles 4 and 7 of Regulation (EU) No 511/2014.
Zainteresirana stran, ki ne predstavlja uporabnikov, pač pa je vključena v dostop, zbiranje, posredovanje ali trženje genskih virov ali razvijanje ukrepov in politike v zvezi z genskimi viri, v svojem zahtevku predloži informacije iz Priloge IV k tej uredbi o svojem legitimnem interesu glede razvoja in nadzora kombinacije postopkov, orodij ali mehanizmov, ki uporabniku, kadar jih učinkovito izvaja, omogočajo izpolnjevanje obveznosti iz členov 4 in 7 Uredbe (EU) št. 511/2014.
The Commission shall send a copy of the application and supporting documentation to the competent authorities of all the Member States.
Komisija pošlje izvod zahtevka in podporne dokumentacije pristojnim organom vseh držav članic.
The competent authorities may submit comments to the Commission regarding the application within two months of receiving the documents referred to in paragraph 3.
Pristojni organi lahko Komisiji predložijo pripombe glede zahtevka v dveh mesecih od prejema dokumentov iz odstavka 3.
The Commission shall acknowledge receipt of an application and provide the applicant with a reference number within 20 working days from the date of receipt of the application.
Komisija potrdi prejem zahtevka in vložniku v 20 delovnih dneh od prejema zahtevka izda referenčno številko.
The Commission shall provide the applicant with an indicative time limit within which a decision on the application will be taken.
Komisija vložnika obvesti o okvirnem roku za sprejem odločitve o zahtevku.
The Commission shall inform the applicant if additional information or documentation is required in order for it to carry out the assessment of the application.
Komisija obvesti vložnika, če so za oceno zahtevka potrebne dodatne informacije ali dokumentacija.
The applicant shall submit to the Commission any additional information and documentation requested without undue delay.
Vložnik brez nepotrebnega odlašanja Komisiji predloži vse zahtevane dodatne informacije in dokumentacijo.
The Commission shall send a copy of the documents referred to in paragraph 6 to the competent authorities of all the Member States.
Komisija pošlje izvod dokumentov iz odstavka 6 pristojnim organom vseh držav članic.
The competent authorities may submit comments to the Commission regarding the information or documentation referred to in paragraph 6 within two months of receiving the copy of those documents.
Pristojni organi lahko Komisiji predložijo pripombe v zvezi z informacijami ali dokumentacijo iz odstavka 6 v dveh mesecih po prejemu izvoda navedenih dokumentov.
The Commission shall inform the applicant each time it revises the indicative time limit within which a decision on the application will be taken due to the necessity to obtain additional information or documents for the assessment of the application.
Komisija vložnika obvesti vsakič, ko spremeni okvirni rok za sprejem odločitve o zahtevku, ker potrebuje dodatne informacije ali dokumente za oceno zahtevka.
The Commission shall inform the applicant in writing of the status of the assessment of the application at least every six months.
Komisija vsaj vsakih šest mesecev vložnika pisno obvesti o stanju ocene zahtevka.
Recognition and withdrawal of recognition as best practice
Priznanje in preklic priznanja najboljše prakse
Where the Commission decides to grant recognition as best practice under Article 8(2) of Regulation (EU) No 511/2014 or to withdraw the recognition of best practice under Article 8(5) of that Regulation, the Commission shall inform of that decision without undue delay the association of users or the other interested parties, as well as the competent authorities of the Member States.
Kadar se Komisija odloči, da bo priznala najboljšo prakso v skladu s členom 8(2) Uredbe (EU) št. 511/2014 ali preklicala priznanje najboljše prakse v skladu s členom 8(5) navedene uredbe, o navedeni odločitvi brez nepotrebnega odlašanja obvesti združenje uporabnikov ali druge zainteresirane strani ter pristojne organe držav članic.
The Commission shall state reasons for its decision to grant recognition as best practice or to withdraw the recognition of best practice and it shall publish that decision in the register established under Article 8(6) of Regulation (EU) No 511/2014.
Komisija navede razloge za svojo odločitev o priznanju najboljše prakse ali preklicu priznanja najboljše prakse in navedeno odločitev objavi v registru, vzpostavljenem v skladu s členom 8(6) Uredbe (EU) št. 511/2014.
Information on subsequent changes to a recognised best practice
Informacije o poznejših spremembah priznane najboljše prakse
Where the Commission is informed, pursuant to Article 8(3) of Regulation (EU) No 511/2014, of any changes or updates made to a recognized best practice, the Commission shall send a copy of that information to the competent authorities of all the Member States.
Kadar je Komisija v skladu s členom 8(3) Uredbe (EU) št. 511/2014 obveščena o kakršnih koli spremembah ali posodobitvah priznane najboljše prakse, izvod navedenih informacij pošlje pristojnim organom vseh držav članic.
The competent authorities may submit comments to the Commission regarding such changes or updates within two months of receiving the information.
Pristojni organi lahko Komisiji predložijo pripombe v zvezi s takimi spremembami ali posodobitvami v dveh mesecih po prejemu informacij.
The Commission shall assess, taking into consideration the comments referred to in paragraph 2 of this Article, whether the changed or updated combination of procedures, tools or mechanisms still enables users to comply with their obligations provided for in Articles 4 and 7 of Regulation (EU) No 511/2014.
Komisija ob upoštevanju pripomb iz odstavka 2 tega člena oceni, ali spremenjena ali posodobljena kombinacija postopkov, orodij ali mehanizmov še vedno omogoča uporabnikom, da izpolnjujejo svoje obveznosti iz členov 4 in 7 Uredbe (EU) št. 511/2014.
The competent authorities shall inform the Commission without undue delay of any information resulting from checks carried out pursuant to Article 9 of Regulation (EU) No 511/2014 indicating non-compliance with Articles 4 and 7 of that Regulation, which may indicate possible deficiencies in the best practice.
Pristojni organi brez nepotrebnega odlašanja obvestijo Komisijo o vseh informacijah, ki izhajajo iz pregledov, izvedenih v skladu s členom 9 Uredbe (EU) št. 511/2014, in ki kažejo na neizpolnjevanje obveznosti iz členov 4 in 7 navedene uredbe, iz česar je mogoče sklepati, da je najboljša praksa morebiti pomanjkljiva.
Deficiency in best practice
Pomanjkljivost najboljše prakse
Where the Commission receives substantiated information regarding repeated or significant cases of non-compliance with Articles 4 and 7 of Regulation (EU) No 511/2014 by a user implementing a best practice, the Commission shall request the association of users or the other interested parties to submit observations regarding the alleged non-compliance and whether those cases indicate possible deficiencies in the best practice.
Kadar Komisija prejme utemeljene informacije glede ponavljajočih se ali pomembnih primerov neizpolnjevanja obveznosti iz členov 4 in 7 Uredbe (EU) št. 511/2014 s strani uporabnika, ki izvaja najboljšo prakso, od združenja uporabnikov ali drugih zainteresiranih strani zahteva, da predložijo opažanja glede domnevnega neizpolnjevanja obveznosti in morebitnih pomanjkljivosti najboljše prakse v navedenih primerih.
Where the association of users or the other interested parties submit observations, they shall do so within three months.
Kadar združenje uporabnikov ali druge zainteresirane strani predložijo opažanja, to storijo v treh mesecih.
The Commission shall examine those observations and any supporting documentation and send copies thereof to the competent authorities of all the Member States.
Komisija preuči navedena opažanja in vso podporno dokumentacijo ter pošlje izvode dokumentov pristojnim organom vseh držav članic.
The competent authorities may submit comments to the Commission regarding those observations and supporting documentation within two months of receiving the copy of those documents.
Pristojni organi lahko Komisiji predložijo pripombe v zvezi z navedenimi opažanji in podporno dokumentacijo v dveh mesecih po prejemu izvoda navedenih dokumentov.
Where the Commission examines possible deficiencies in a best practice and cases of non-compliance with the obligations provided for in Articles 4 and 7 of Regulation (EU) No 511/2014, as referred to in Article 8(4) of that Regulation, the association of users or the other interested parties subject to examination shall co-operate with the Commission and assist it in its actions.
Kadar Komisija preuči morebitne pomanjkljivosti najboljše prakse in primere neizpolnjevanja obveznosti iz členov 4 in 7 Uredbe (EU) št. 511/2014, kot je navedeno v členu 8(4) navedene uredbe, združenje uporabnikov ali druge zainteresirane strani, ki so predmet pregleda, sodelujejo s Komisijo in ji pomagajo pri njenem delovanju.
Where the association of users or the other interested parties subject to examination fails to do so, the Commission may, without further consideration, withdraw recognition of the best practice.
Kadar združenje uporabnikov ali druge zainteresirane strani, ki so predmet pregleda, ne prekličejo priznanja najboljše prakse, lahko to stori Komisija brez nadaljnje obravnave.
The results of the examination carried out by the Commission shall be conclusive and shall include any remedial actions to be taken by the association of users or the other interested parties.
Rezultati pregleda Komisije so dokončni in vključujejo morebitne popravne dejavnosti, ki jih mora izvesti združenje uporabnikov ali druge zainteresirane strani.
The examination may also result in a decision to withdraw recognition of the best practice.
Rezultat pregleda je lahko tudi odločitev o preklicu priznanja najboljše prakse.
The Commission shall review the functioning and effectiveness of this Regulation, taking into account the experience gathered in its implementation and with a view to its potential revision.
Komisija pregleda delovanje in učinkovitost te uredbe, pri čemer upošteva izkušnje, pridobljene pri njenem izvajanju, in njeno morebitno revizijo.